(PATH) Uipath - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90364P1057
PATH: Robotic Process Automation, AI, Cloud, Low-Code, Process Mining
UiPath Inc. is a leading provider of an end-to-end automation platform that enables organizations to streamline operations through advanced robotic process automation (RPA) solutions. With a strong presence in the United States, Romania, the United Kingdom, the Netherlands, and other international markets, the company delivers software robots capable of mimicking human actions with high precision and speed. Its platform integrates AI, ML, and NLP capabilities to enhance decision-making and information processing, allowing users to combine UI automations, API integrations, and AI-based document understanding into a single workflow. The platform also offers multi-tenant enterprise deployment with robust security and governance features, as well as Automation Cloud for rapid deployment without infrastructure overhead. Its intuitive, low-code interface with drag-and-drop functionality empowers users to design and execute automations efficiently. Additionally, UiPath provides process mining capabilities to analyze digital footprints, track automation performance, and generate actionable insights for continuous process optimization. The company serves a diverse range of industries, including financial services, healthcare, manufacturing, retail, and the public sector. Founded in 2005 and headquartered in New York, UiPath has established itself as a pioneer in the RPA space, driving digital transformation for enterprises globally.
3-Month Forecast: Based on the provided
Additional Sources for PATH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PATH Stock Overview
Market Cap in USD | 5,763m |
Sector | Technology |
Industry | Software - Infrastructure |
GiC Sub-Industry | Systems Software |
IPO / Inception | 2021-04-21 |
PATH Stock Ratings
Growth Rating | -64.4 |
Fundamental | 25.6 |
Dividend Rating | 0.0 |
Rel. Strength | -44.1 |
Analysts | 3.13/5 |
Fair Price Momentum | 8.17 USD |
Fair Price DCF | 4.94 USD |
PATH Dividends
No Dividends PaidPATH Growth Ratios
Growth Correlation 3m | -74.4% |
Growth Correlation 12m | -21.3% |
Growth Correlation 5y | -71.1% |
CAGR 5y | -35.33% |
CAGR/Max DD 5y | -0.40 |
Sharpe Ratio 12m | -0.07 |
Alpha | -54.92 |
Beta | 1.411 |
Volatility | 62.01% |
Current Volume | 11389.3k |
Average Volume 20d | 16219.2k |
As of May 02, 2025, the stock is trading at USD 11.88 with a total of 11,389,257 shares traded.
Over the past week, the price has changed by +4.95%, over one month by +13.14%, over three months by -16.40% and over the past year by -38.25%.
Neither. Based on ValueRay Fundamental Analyses, Uipath is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.60 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PATH as of May 2025 is 8.17. This means that PATH is currently overvalued and has a potential downside of -31.23%.
Uipath has received a consensus analysts rating of 3.13. Therefor, it is recommend to hold PATH.
- Strong Buy: 2
- Buy: 1
- Hold: 20
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, PATH Uipath will be worth about 9.8 in May 2026. The stock is currently trading at 11.88. This means that the stock has a potential downside of -17.76%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 12.3 | 3.6% |
Analysts Target Price | 15.7 | 31.9% |
ValueRay Target Price | 9.8 | -17.8% |